Byers Capital

Funding rounds backed by Byers Capital.

Export CSV
Funding disclosed in full
$21M
Median round
$21M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Oryon Cell Therapies

Develops autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders

$21MSeries ABiotechUnited States
2 participantsByers CapitalNeuro.VC